Try our Advanced Search for more refined results

In re Vaxart, Inc. Securities Litigation

  1. November 09, 2020

    Biotech Co. Investors Battle To Lead COVID-19 Vaccine Suit

    Investors vying for the lead role in a proposed class action alleging San Francisco-headquartered biotechnology company Vaxart Inc. lied about its COVID-19 vaccine candidate traded jabs in competing responses to each other's pleas to lead the proposed class.

  2. August 24, 2020

    Biotech Co. Lied About COVID-19 Vaccine, Investors Say

    Investors in Vaxart Inc. accused the San Francisco-headquartered biotechnology company of lying about its COVID-19 vaccine candidate in order to inflate its stock price, according to a complaint filed Monday in California federal court.